…
Stepan Company, together with its subsidiaries, produces and sells specialty and intermediate chemicals to other manufacturers for use in various end products worldwide. It operates through three segments: Surfactants, Polymers, and Specialty Products. The Surfactants segment offers surfactants that are used as principal ingredients in consumer and industrial cleaning and disinfection products, including detergents for washing clothes, dishes, carpets, and floors and walls, as well as shampoos and body washes; and other applications, such as fabric softeners, germicidal quaternary compounds, disinfectants, and lubricating ingredients. Its surfactants are also used in various applications, including emulsifiers for spreading agricultural products; and industrial applications comprising latex systems, plastics, and composites. The Polymers segment provides polyurethane polyols that are used in the manufacture of rigid foam for thermal insulation in the construction industry, as well as a base raw material for coatings, adhesives, sealants, and elastomers (CASE); polyester resins, including liquid and powdered products, which are used in CASE applications; and phthalic anhydride that is used in unsaturated polyester resins, alkyd resins, and plasticizers for applications in construction materials, as well as components of automotive, boating, and other consumer products. The Specialty Products segment offers flavors, emulsifiers, and solubilizers for use in food, flavoring, nutritional supplement, and pharmaceutical applications. Stepan Company was founded in 1932 and is headquartered in Northbrook, Illinois.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Stepan Company manufactures specialty chemicals—surfactants, oleochemicals and polymer intermediates—for household and industrial cleaning, personal care, agrochemical and polyurethane markets. Long-term growth may be supported by rising demand for formulated surfactants, a shift toward bio-based feedstocks and Stepan's global manufacturing and R&D capabilities, which appears positioned to serve customers seeking more sustainable inputs.
Key risks include feedstock and commodity price volatility, regulatory and environmental compliance costs, cyclical end-market demand and competition from larger chemical producers, which investors should monitor.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Income before tax | 188.70M | 172.54M | 171.07M | 125.90M | 139.92M |
| Minority interest | 0.00M | -0.09M | 0.89M | -0.03M | -0.01M |
| Net income | 147.15M | 137.80M | 126.77M | 103.13M | 112.76M |
| Selling general administrative | 92.78M | 99.80M | 97.35M | 97.72M | 76.91M |
| Selling and marketing expenses | 59.03M | 59.19M | 55.54M | 56.96M | 56.32M |
| Gross profit | 427.07M | 395.81M | 383.61M | 339.71M | 341.50M |
| Reconciled depreciation | 94.65M | 90.88M | 81.86M | 78.70M | 81.11M |
| Ebit | 105.15M | 86.61M | 92.09M | 54.05M | 75.48M |
| Ebitda | 199.80M | 177.49M | 173.95M | 132.75M | 156.59M |
| Depreciation and amortization | 94.65M | 90.88M | 81.86M | 78.70M | 81.11M |
| Non operating income net other | - | 7.51M | 4.95M | 4.57M | -0.72M |
| Operating income | 105.15M | 86.61M | 92.09M | 54.05M | 151.42M |
| Other operating expenses | 2564.65M | 2171.83M | 1697.02M | 1728.74M | 1839.85M |
| Interest expense | 9.81M | 7.01M | 7.58M | 11.65M | 12.60M |
| Tax provision | 41.55M | 34.64M | 43.41M | 22.80M | 27.17M |
| Interest income | 9.81M | 5.75M | 5.41M | 5.72M | 1.83M |
| Net interest income | -9.81M | -5.75M | -5.41M | -5.93M | -10.77M |
| Extraordinary items | - | - | - | - | 0.38M |
| Non recurring | - | 3.35M | 1.21M | 2.74M | 2.59M |
| Income tax expense | 41.55M | 34.64M | 43.41M | 22.80M | 27.17M |
| Total revenue | 2773.27M | 2345.97M | 1869.75M | 1858.74M | 1993.86M |
| Total operating expenses | 218.45M | 221.68M | 210.88M | 209.71M | 187.50M |
| Cost of revenue | 2346.20M | 1950.16M | 1486.14M | 1519.03M | 1652.35M |
| Total other income expense net | 83.56M | 85.93M | 78.98M | 71.85M | -3.31M |
| Net income from continuing ops | 147.15M | 137.90M | 127.66M | 103.10M | 112.75M |
| Net income applicable to common shares | 147.15M | 137.80M | 126.77M | 103.13M | 112.76M |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Total assets | 2433.17M | 2065.61M | 1752.34M | 1579.37M | 1484.67M |
| Intangible assets | 58.03M | 60.78M | 24.07M | 15.35M | 14.24M |
| Other current assets | 31.61M | 29.10M | 35.61M | 22.92M | 22.15M |
| Total liab | 1267.11M | 991.42M | 763.97M | 686.87M | 700.14M |
| Total stockholder equity | 1166.07M | 1074.19M | 986.69M | 891.78M | 783.77M |
| Deferred long term liab | - | 12.49M | 20.75M | 23.39M | 18.67M |
| Other current liab | 162.81M | 136.40M | 141.95M | 121.27M | 95.57M |
| Common stock | 26.84M | 26.76M | 26.66M | 26.49M | 26.31M |
| Capital stock | 26.84M | 26.76M | 26.66M | 26.49M | 26.31M |
| Retained earnings | 1250.13M | 1133.55M | 1023.83M | 922.46M | 813.45M |
| Other liab | 90.87M | 168.08M | 186.60M | 119.57M | 128.82M |
| Good will | 95.92M | 97.19M | 27.97M | 26.09M | 22.95M |
| Other assets | 315.07M | 301.64M | 111.98M | 41.44M | 34.63M |
| Cash | 173.75M | 159.19M | 349.94M | 315.38M | 300.19M |
| Cash and equivalents | 173.75M | 159.19M | 349.94M | 315.38M | 300.19M |
| Total current liabilities | 670.65M | 500.48M | 416.55M | 339.11M | 338.58M |
| Current deferred revenue | - | - | 20.75M | - | - |
| Net debt | 413.39M | 163.68M | -189.13M | -116.85M | -61.17M |
| Short term debt | 132.11M | 40.72M | 37.86M | 23.57M | 37.06M |
| Short long term debt | 132.11M | 40.72M | 37.86M | 23.57M | 37.06M |
| Short long term debt total | 587.14M | 322.86M | 160.81M | 198.53M | 239.02M |
| Other stockholder equity | 56.61M | 67.12M | 73.09M | 79.00M | 85.01M |
| Property plant equipment | 1073.30M | 850.60M | 682.67M | 639.32M | 608.89M |
| Total current assets | 1044.80M | 913.37M | 905.65M | 818.79M | 802.53M |
| Long term investments | 23.29M | 34.49M | 30.65M | 28.23M | 25.08M |
| Net tangible assets | 1012.12M | 1074.19M | 986.22M | 880.00M | 746.57M |
| Short term investments | - | - | 30.65M | - | - |
| Net receivables | 436.91M | 419.54M | 301.32M | 276.84M | 280.02M |
| Long term debt | 455.03M | 322.86M | 160.81M | 198.53M | 239.02M |
| Inventory | 402.53M | 305.54M | 218.78M | 203.65M | 200.16M |
| Accounts payable | 375.73M | 323.36M | 236.75M | 194.28M | 205.95M |
| Noncontrolling interest in consolidated entity | - | - | 1.67M | 0.71M | 0.76M |
| Accumulated other comprehensive income | -167.51M | -153.24M | -136.88M | -136.17M | -141.48M |
| Common stock total equity | - | 26.76M | 26.66M | 26.49M | 26.31M |
| Retained earnings total equity | - | 1133.55M | 1023.83M | 922.46M | 813.45M |
| Treasury stock | - | -153.70M | -133.63M | -114.14M | -97.39M |
| Non currrent assets other | 127.65M | 301.64M | 164.02M | 121.26M | -7.71M |
| Non current assets total | 1388.37M | 1152.24M | 846.68M | 760.58M | 682.14M |
| Capital lease obligations | 50.56M | 56.67M | 51.57M | 29.65M | - |
| Long term debt total | 455.03M | 322.86M | 160.81M | 198.53M | 239.02M |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Investments | -308.09M | -376.83M | -139.03M | -112.67M | -107.81M |
| Change to liabilities | 53.21M | 42.69M | 55.13M | -15.87M | -24.09M |
| Total cashflows from investing activities | -308.09M | -376.83M | -139.03M | -112.67M | -107.81M |
| Net borrowings | 223.69M | 165.00M | -23.57M | -53.92M | -14.67M |
| Total cash from financing activities | 166.21M | 117.33M | -64.93M | -90.49M | -51.65M |
| Change to operating activities | 3.37M | -2.71M | -17.56M | 1.05M | -4.71M |
| Net income | 147.15M | 137.90M | 127.66M | 103.10M | 112.75M |
| Change in cash | 14.56M | -190.75M | 34.55M | 15.19M | 1.30M |
| Begin period cash flow | 159.19M | 349.94M | 315.38M | 300.19M | 298.89M |
| End period cash flow | 173.75M | 159.19M | 349.94M | 315.38M | 300.19M |
| Total cash from operating activities | 160.76M | 72.14M | 235.22M | 218.43M | 171.13M |
| Depreciation | 94.65M | 90.88M | 81.86M | 78.70M | 81.11M |
| Other cashflows from investing activities | -6.54M | -182.35M | -13.24M | -7.09M | -21.17M |
| Dividends paid | -30.57M | -28.08M | -25.41M | -23.10M | 20.86M |
| Change to inventory | -99.39M | -79.26M | -15.36M | 28.46M | -26.83M |
| Change to account receivables | -54.17M | -104.23M | -23.42M | 4.89M | 5.20M |
| Sale purchase of stock | -24.95M | -16.97M | -15.25M | -13.18M | -15.50M |
| Other cashflows from financing activities | 259.59M | -3.99M | -3.63M | -3.33M | -4.79M |
| Change to netincome | -12.08M | -22.02M | 5.50M | 2.14M | 25.29M |
| Capital expenditures | 301.55M | 194.48M | 125.79M | 105.57M | 86.65M |
| Change receivables | - | -104.23M | -23.42M | 4.89M | 5.20M |
| Cash flows other operating | - | 6.19M | 3.85M | 17.00M | -2.30M |
| Exchange rate changes | - | -3.39M | 3.31M | -0.08M | -10.37M |
| Cash and cash equivalents changes | - | -190.75M | 34.55M | 15.19M | 1.30M |
| Change in working capital | -68.96M | -141.51M | 10.21M | 19.34M | -45.69M |
| Stock based compensation | 13.85M | 11.72M | 10.08M | 8.87M | 6.84M |
| Other non cash items | 1.52M | 6.76M | 9.91M | 13.43M | 5.26M |
| Free cash flow | -140.79M | -122.35M | 109.42M | 112.86M | 84.48M |
Sector: Basic Materials Industry: Specialty Chemicals
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| SCL Stepan Company |
-0.14 0.22% |
65.64 | 41.98 | 23.87 | 0.85 | 1.72 | 1.10 | 15.67 |
| LIN Linde plc Ordinary Shares |
-4.18 0.81% |
510.93 | 33.77 | 28.90 | 6.56 | 5.42 | 7.03 | 18.92 |
| AIQUY Air Liquide SA ADR |
- -% |
41.96 | 30.69 | 24.81 | 4.70 | 4.10 | 4.36 | 15.61 |
| AIQUF L'Air Liquide S.A |
-0.00 0.00% |
208.77 | 29.78 | 22.68 | 4.54 | 3.98 | 4.50 | 15.90 |
| SHW Sherwin-Williams Co |
-0.23 0.07% |
343.92 | 33.33 | 27.40 | 3.38 | 20.60 | 3.88 | 21.36 |
Stepan Company, together with its subsidiaries, produces and sells specialty and intermediate chemicals to other manufacturers for use in various end products worldwide. It operates through three segments: Surfactants, Polymers, and Specialty Products. The Surfactants segment offers surfactants that are used as principal ingredients in consumer and industrial cleaning and disinfection products, including detergents for washing clothes, dishes, carpets, and floors and walls, as well as shampoos and body washes; and other applications, such as fabric softeners, germicidal quaternary compounds, disinfectants, and lubricating ingredients. Its surfactants are also used in various applications, including emulsifiers for spreading agricultural products; and industrial applications comprising latex systems, plastics, and composites. The Polymers segment provides polyurethane polyols that are used in the manufacture of rigid foam for thermal insulation in the construction industry, as well as a base raw material for coatings, adhesives, sealants, and elastomers (CASE); polyester resins, including liquid and powdered products, which are used in CASE applications; and phthalic anhydride that is used in unsaturated polyester resins, alkyd resins, and plasticizers for applications in construction materials, as well as components of automotive, boating, and other consumer products. The Specialty Products segment offers flavors, emulsifiers, and solubilizers for use in food, flavoring, nutritional supplement, and pharmaceutical applications. Stepan Company was founded in 1932 and is headquartered in Northbrook, Illinois.
1101 Skokie Boulevard, Northbrook, IL, United States, 60062
847 446 7500
2453
| Name | Title | Year Born |
|---|---|---|
| Mr. Scott R. Behrens | CEO, COO, Pres & Director | 1970 |
| Mr. Luis E. Rojo | VP & CFO | 1973 |
| Mr. Arthur W. Mergner | Exec. VP of Supply Chain | 1964 |
| Dr. Jason Scott Keiper Ph.D. | VP & Chief Technology and Sustainability Officer | 1975 |
| David B. Mattingly | VP & Chief Compliance Officer | NA |
| Mr. David G. Kabbes | VP, Gen. Counsel & Sec. | 1963 |
| Mr. Mark F. Mydlach | VP of Sales | NA |
| Ms. Janet A. Catlett | VP & Chief HR Officer | 1977 |
| Mr. Matthew John Eaken | VP & Corp. Controller | 1963 |
| Mr. John V. Venegoni | Consultant | 1959 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.